| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0006 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.42 | 0.007 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |